Sarah E.M. Herman

CAL-101, a p110δ selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability

Brian J. Lannutti, Sarah Meadows, Sarah E.M. Herman et al. · Blood · 2010 · 712 citations · Full text

Phosphatidylinositol 3-kinase-δ inhibitor CAL-101 shows promising preclinical activity in chronic lymphocytic leukemia by antagonizing intrinsic and extrinsic cellular survival signals

Sarah E.M. Herman, Amber Gordon, Amy J. Wagner et al. · Blood · 2010 · 541 citations · Full text

Incidence and risk factors of bleeding-related adverse events in patients with chronic lymphocytic leukemia treated with ibrutinib

Andrew Lipsky, Mohammed Z.H. Farooqui, Xin Tian et al. · Haematologica · 2015 · 165 citations · Full text

Tetraspanin CD37 Directly Mediates Transduction of Survival and Apoptotic Signals

Rosa Lapalombella, Yuh-Ying Yeh, Liwen Wang et al. · Cancer Cell · 2012 · 136 citations · Full text

ER stress and autophagy: new discoveries in the mechanism of action and drug resistance of the cyclin-dependent kinase inhibitor flavopiridol

Emilia Mahoney, David Lucas, Sneha Gupta et al. · Blood · 2012 · 103 citations · Full text